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To determine the pandemic potential of Vibrio cholerae, one must demonstrate both the presence of O1
antigen and the production of enterotoxin (CT). Tissue culture or enzyme-linked immunosorbent assays
(ELISAs) for CT have been limited to research and reference laboratories. A kit for detecting CT by reversed
passive latex agglutination is now commercially available and was used to test 168 strains of V. cholerae O1 and
non-Ol. When compared with the routine ELISA, the latex test was 98% accurate (86 of 88) for serogroup O1
strains and 100% accurate (80 of 80) for non-Ol strains. For both O1 and non-Ol study strains, the sensitivity
of the latex agglutination test was 0.97 and the specificity was 1.00 when results were compared with ELISA
results. The latex test is commercially available and has the advantages of being less complicated and less
time-consuming than the ELISA.
The outstanding characteristic of Vibrio cholerae is the
ability of virulent strains to produce a potent enterotoxin
responsible for the watery diarrhea observed in affected
patients. V. cholerae enterotoxin (CT) was first detected by
its ability to cause fluid accumulation in the ligated rabbit
ileal loop (5) and later in similarly difficult bioassays such as
the infant rabbit infection model (6), rabbit skin test (3), and
Y-1 adrenal cell (12) and Chinese hamster ovary cell (7)
tissue culture assays. In the 1970s a sandwich enzyme-linked
immunosorbent assay (ELISA) for cholera toxin was devel-
oped (15) and widely used in many reference and research
laboratories. A later modification of the ELISA that used the
purified GM1 ganglioside receptor as the capture molecule
provided a more standardized approach (14).
Although genetic probe assays for CT have been devel-
oped (2, 8), their current formats continue to require at least
48 h and involve the use of radioactive isotopes. Initially,
Kaper et al. (8) used a radioactive probe consisting of
Escherichia coli heat-labile enterotoxin DNA to demonstrate
that enterotoxigenic strains of V. cholerae Q1 isolated from
specimens from Texas and Louisiana carried toxin operon
duplications. Klontz et al. (9) used a synthetic oligonucleo-
tide DNA probe for CT to show that V. cholerae Q1 strains,
with a single toxin gene copy, can also occur on the Gulf
Coast of the United States.
Recently, a latex agglutination kit (VET-RPLA; Oxoid
U.S.A., Inc., Columbia, Md.) has become commercially
available and offers the potential of a rapid, simple diagnos-
tic assay for CT and E. coli heat-labile enterotoxin. The
purpose of this study was to compare the accuracy, sensi-
tivity, and specificity of the latex agglutination kit with those
of a routine ELISA for CT.
A total of 168 strains of V. cholerae (88 serogroup Q1
strains and 80 non-Q1 strains) were used for this study. They
were derived from specimens submitted to the Enteric
Bacteriology Section of the Centers for Disease Control. All
strains were tested for CT by both the ELISA procedure and
the latex agglutination kit. Culture materials, conditions, and
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methods were selected on the basis of previous experience
with V. cholerae Q1 Inaba biotype El Tor isolates from the
U.S. Gulf Coast region. Several studies have shown that
optimal culture conditions vary between biotypes and be-
tween Q1 and non-Q1 serotypes of toxigenic isolates (4, 11,
13). For example, Craig (4) reported that a stationary culture
was more effective than an aerated culture for V. cholerae El
Tor isolates but not for classical vibrios in producing CT.
The culture medium used in this study for producing V.
cholerae enterotoxin was a modification of the medium
described by Kusama and Craig (10). The medium contained
3% Casamino Acids, 0.4% yeast extract (Difco Laborato-
ries), 0.05% K2HPQ4, and 0.2% filter-sterilized glucose (pH
7.0). Cultures were grown in 5-ml volumes in screw-cap
tubes (16 by 125 mm) without shaking at 30°C for 18 to 24 h.
After incubation, tubes were centrifuged at 1,000 x g and
25°C for 30 min. One milliliter of supernatant was transferred
to a 1.5-ml microcentrifuge tube and centrifuged at 8,000 x
g and 4°C for 15 min. In order to avoid potential binding of
toxin protein to nitrocellulose or any other membrane ma-
trix, filtration was not used. The supernatants of 134 (54
serogroup Q1 strains and 80 non-Q1 strains) of the study
isolates were assayed simultaneously by latex agglutination
and ELISA. The supernatants of 34 serogroup Q1 isolates
were assayed only by the latex agglutination test in this
study, and results were compared with those from previous
ELISAs; if disagreements were noted, the ELISA was
repeated.
ELISA. The sandwich ELISA used burro anti-CT ad-
sorbed to round-bottom microdilution wells as the capture
molecule. Culture supernatants were added to the coated
wells. Cholera toxin molecules in the supernatant bound to
the capture antibody and reacted with a second antibody,
rabbit anti-CT. Alkaline phosphatase-labeled goat anti-rabbit
immunoglobulin was added and acted as the detector mole-
cule. When the enzyme substrate p-nitrophenyl phosphate
was added, the bound alkaline phosphatase degraded the
substrate, forming a yellow product that indicated the pres-
ence of CT. Color changes were observed visually and
measured by spectrophotometer. A culture was considered
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TABLE 1. Comparison of VET-RPLA and ELISA results
in detection of cholera toxin
No. of isolates No. of
cholera Region ELISA VET-RPLA dis-
serogroup Total agree-
Toxin+ Toxin- Toxin+ Toxin- ments
01 United Statesa 43 23 20 23 20 0
01 Foreign 45 35 10 33 12 2b
Non-01 United States 75 3 72 3 72 0
Non-01 Foreign 5 0 5 0 5 0
a Continental United States including Alaska.
b One isolate was VET-RPLA negative, ELISA positive, Y-1 positive, and
probe positive, and one isolate was VET-RPLA negative, ELISA positive,
cytotoxic in the Y-1 assay, and probe positive.
positive or toxigenic when the test well had an optical
density at least twice that of the negative control wells.
Three positive (toxigenic) control strains (569B, E5906, and
ATCC 14035) and three negative (nontoxigenic) control
strains (X316, 692, and 2634-78) were used on each ELISA
plate.
Latex agglutination test. Twofold dilutions of each test
sample were made in each of two rows (eight wells per row)
of a 96-well microdilution plate. Samples (25 ,ul each) were
diluted in phosphate-buffered saline containing 0.5% bovine
serum albumin; the last well contained diluent only. Sensi-
tized latex (latex suspension sensitized with specific rabbit
immunoglobulin G against V. cholerae enterotoxin; 25 ,il)
was then added to each well of the first row. An identical
amount of control latex (latex suspension coated with non-
immune rabbit globulin) was added to each well of the
second row. Microdilution plates were then manually ro-
tated to ensure mixing, covered, and left undisturbed at
room temperature for 20 to 24 h, after which each well was
examined macroscopically for agglutination. One positive
(E5906) and one negative (X316) control strain were included
on each latex test plate.
Any discordant results were further examined by the Y-1
adrenal cell assay, which measures toxic activity, and a
synthetic oligonucleotide probe (ctxall) for the CT gene.
Additionally, many of the strains in this study had been
hybridized with the CT probes as described elsewhere (2, 9).
For the 168 V. cholerae strains studied, the latex aggluti-
nation test results disagreed with ELISA results in only two
instances, when isolates tested positive by ELISA but
negative by latex agglutination (i.e., 99% agreement) (Table
1). For both Q1 and non-Q1 study strains, results of the latex
agglutination test compared with results of the ELISA gave
a sensitivity of 0.97 and a specificity of 1.00. The accuracy of
the latex agglutination test was 98% (86 of 88) for serogroup
01 strains and 100% (80 of 80) for non-Q1 strains when
results were compared with ELISA results. In every case,
ELISA results obtained visually and spectrophotometrically
were in agreement. The 88 Q1 isolates tested included 43
strains from the continental United States and 45 foreign
strains. The 80 non-Q1 isolates tested included 75 U.S.
strains and 5 foreign strains. The two Q1 isolates that yielded
discordant results were both from outside the continental
United States (Australia and Mali). Because both ELISA
and the latex test are based on antigen-antibody reactions,
we tested the two strains that did not agree in the Y-1 adrenal
cell assay for toxic activity. The African strain was found to
produce CT, as indicated by the apparently more sensitive
ELISA. The strain from Australia was cytotoxic in the Y-1
adrenal cell assay. This cytotoxicity was not neutralizable by
rabbit anti-cholera toxin. The two Q1 isolates both tested
positive for the CT gene after overnight hybridization with
the probe for CT. No disagreements were found between the
ELISA and latex agglutination test results for the 118 U.S.
isolates, including strain 2489-86, which had been shown to
differ from other U.S. isolates in having only one apparent
copy of the CT gene (9). The fact that both disagreements
involved foreign isolates could indicate that the growth
conditions used in this study were not optimal for CT
production by strains from geographic areas other than the
United States. Kaper et al. (8) reported that most El Tor
strains isolated from outside the United States had only a
single CT gene copy. Our positive control strain E5906 was
isolated in Dacca, Bangladesh, and was a low-level toxin
producer in the quantitative Y-1 assay. In contrast, all
toxigenic Gulf Coast strains, with the exception of strain
2489-86, possess toxin operon duplications.
The serogroup Q1 characteristic has been the primary
marker for pandemic, pathogenic V. cholerae strains. It is
becoming apparent, however, that not all V. cholerae Q1
strains are toxigenic and they may not be pathogenic. Strains
of nontoxigenic V. cholerae Q1 have been isolated from
humans, sewage, oysters, and surface water (1). Most clin-
ical laboratories do not test for the ability of isolates to
produce CT because the laboratories lack tissue culture
facilities and CT-ELISA reagents are not readily available.
Instead, suspect isolates are sent to reference laboratories
for toxin testing. This situation results in considerable delay
in identifying toxigenic V. cholerae isolates that must be
reported immediately to the World Health Organization. If
clinical laboratories could quickly determine the toxigenicity
of V. cholerae Q1 isolates, the international surveillance and
possible epidemiologic investigation of cholera would be
significantly facilitated.
On the basis of findings from this study, we recommend
the use of the Oxoid latex agglutination kit in clinical as well
as reference laboratories. The kit is designed to detect 1 to 2
ng of cholera toxin per ml and is relatively convenient to use.
Frequently, laboratories receive requests for CT determina-
tions on single specimens. Since the ELISA uses microdilu-
tion plates with precoated wells, it is not an efficient method
for assaying small numbers of specimens. The design of the
latex agglutination test, on the other hand, allows for the
dispensing of requisite amounts of antigens and antibodies
into uncoated microdilution wells. The kit provides diluent
and latex reagents that are ready for use. Therefore, the
format of the latex agglutination test is more appropriate for
the rapid detection of CT in situations involving small
numbers of specimens. Minimal time and effort are needed
for setup and interpretation of results. The latex test is
commercially available and is simpler and faster than the
CT-ELISA. Thus, the VET-RPLA kit is well suited for use
in field studies and by most clinical microbiology laborato-
ries.
Although no false-negative results occurred with the U.S.
isolates when the latex agglutination test was used in this
study, an overall 3.4% false-negative rate was noted. Since a
false-negative reaction is possible and the isolation of V.
cholerae Q1 in the United States is considered to be rela-
tively rare, clinical laboratories should forward V. cholerae
Q1 specimens, regardless of toxin assay result, to a refer-
ence laboratory for confirmation of identification, serotype,
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